InClinica Opens Asia-Pac Office

InClinica, a global, clinical CRO, has opened its new Asia-Pacific office in Kuala Lumpur, along with its subsidiary company, IC LifeSciences.
 
The new office will serve as InClinica’s Asia-Pacific headquarters for clinical research and life science business development in the region. Jeffrey S. Yablon, executive vice president of InClinica and IC LifeSciences, will serve as the head of this location.
 
“InClinica prides itself on the depth of our connections around the globe,” said James Nolan, chief executive officer of InClinica. “Our goal with the new office was to build upon our already solid presence in the Asia-Pacific region. We are adding another layer of depth to our services and further proving our commitment to building a sustainable, global company.”